H3 K27M mutation in rosette-forming glioneuronal tumors: a potential diagnostic pitfall
Virchows Archiv · 2025
DOI: 10.1007/s00428-024-03739-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift Virchows Archiv, 2025. Verfasst von Elena Marastoni und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Diagnostics and Public Health, University of Verona, Policlinico G.B. Rossi, P.le L.A. Scuro, 10, 37138, Verona, Italy. Hauptthemen laut MEDLINE: Mutation, Histones, Glioma, Brain Neoplasms. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Università degli Studi di Verona.
Abstract (Originalsprache)
According to the fifth edition of the World Health Organization (WHO) classification of tumors of the central nervous system (CNS), diffuse midline glioma H3 K27-altered is a grade 4 infiltrative glioma that arises from midline anatomical structures and is characterized by the loss of H3 K27me3 and co-occurring H3 K27M mutation or EZHIP overexpression. However, the H3 K27M mutation has also been observed in circumscribed gliomas and glioneuronal tumors arising in midline anatomical structures, which may result in diagnostic pitfalls. Rosette-forming glioneuronal tumor (RGNT) is a CNS WHO grade 1 neoplasm that histologically features neurocytic and glial components and originates in midline anatomical structures. This study aimed to assess whether RGNTs, similar to other midline tumors, may exhibit immunohistochemical loss of H3 K27me3 and harbor the H3 K27M mutation. All seven analyzed RGNTs displayed immunohistochemical loss of H3 K27me3 in all tumor cells or H3 K27me3 mosaic immunostaining. In one case, H3 K27me3 loss was associated with the H3 K27M mutation, whereas the other six cases did not exhibit any H3 mutations or EZHIP overexpression. During a follow-up period of 23 months, the H3 K27M-mutant case remained unchanged in size despite partial resection, indicating that the H3 mutation may not confer higher biological aggressiveness to RGNT. The immunohistochemical loss of H3 K27me3 co-occurring with the H3 K27M mutation may result in the potential misdiagnosis of RGNT, especially in cases of small biopsy specimens consisting of only the glial component.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Diagnostics and Public Health, University of Verona, Policlinico G.B. Rossi, P.le L.A. Scuro, 10, 37138, Verona, Italy.
- Unit of Anatomic Pathology, Ospedale Pediatrico Bambino Gesù, Rome, Italy.
- Department of Medical and Surgical Sciences and Advanced Technologies, G.F. Ingrassia, Anatomic Pathology, University of Catania, Catania, Italy.
- Unit of Cranial Posterior Fossa Surgery, University and Hospital Trust of Verona, Verona, Italy.
- Department of Neurosciences, University of Verona, Verona, Italy.
- Department of Diagnostics and Public Health, University of Verona, Policlinico G.B. Rossi, P.le L.A. Scuro, 10, 37138, Verona, Italy. valeria.barresi@univr.it.
Förderung
- Università degli Studi di Verona
Zitieren
APA
Marastoni, E., Ammendola, S., Rossi, S., Giovannoni, I., Broggi, G., Masotto, B., Feletti, A., & Barresi, V. (2025). H3 K27M mutation in rosette-forming glioneuronal tumors: a potential diagnostic pitfall. Virchows Archiv. https://doi.org/10.1007/s00428-024-03739-2
Vancouver
Marastoni E, Ammendola S, Rossi S, Giovannoni I, Broggi G, Masotto B, et al. H3 K27M mutation in rosette-forming glioneuronal tumors: a potential diagnostic pitfall. Virchows Archiv. 2025. doi:10.1007/s00428-024-03739-2
BibTeX
@article{Marastoni2025,
author = {Marastoni, Elena and Ammendola, Serena and Rossi, Sabrina and Giovannoni, Isabella and Broggi, Giuseppe and Masotto, Barbara and Feletti, Alberto and Barresi, Valeria},
title = {H3 K27M mutation in rosette-forming glioneuronal tumors: a potential diagnostic pitfall},
journal = {Virchows Archiv},
year = {2025},
doi = {10.1007/s00428-024-03739-2}
}
EUVIMED